share_log

Berenson Acquisition Corp. I Receives Noncompliance Notification From the New York Stock Exchange Regarding Minimum Public Stockholders

Berenson Acquisition Corp. I Receives Noncompliance Notification From the New York Stock Exchange Regarding Minimum Public Stockholders

Berenson Acquisition Corp. I 收到紐約證券交易所關於最低公衆股東的不合規通知
newsfile ·  01/25 08:00

New York, New York--(Newsfile Corp. - January 25, 2024) - Berenson Acquisition Corp. I (NYSE American: BACA) (the "Company") announced it had received a notification dated January 19, 2024 (the "Notice") from the staff of NYSE Regulation of the New York Stock Exchange ("NYSE Regulation") indicating that the Company is not currently in compliance with Section 1003(b)(i)(B) of the NYSE American LLC Company Guide (the "Company Guide"), which requires the Company to maintain a minimum of 300 public stockholders on a continuous basis.

紐約,紐約--(Newsfile Corp.,2024年1月25日)——Berenson Acquisition Corp. I(紐約證券交易所美國股票代碼:BACA)(“公司”)宣佈已收到紐約證券交易所監管局(“紐約證券交易所監管”)工作人員於2024年1月19日發出的通知(“通知”),表明該公司目前未遵守第1003(b)(i)(B)條)的《紐約證券交易所美國有限責任公司公司指南》(“公司指南”),該指南要求公司連續維持至少300名公衆股東。

In accordance with Section 1009 of the Company Guide, the Company has been provided with a period of 30 days to respond with a plan advising of actions it has taken or will take to regain compliance with the minimum public shareholders requirement by September 30, 2024. The staff of NYSE Regulation will review the business plan. If NYSE Regulation accepts the plan, the Company will be notified in writing and will be subject to periodic reviews including quarterly monitoring for compliance with such plan. If NYSE Regulation does not accept the plan, the Company will be subject to delisting procedures.

根據公司指南第1009節,公司有30天的時間來回應一項計劃,建議其爲在2024年9月30日之前恢復遵守最低公衆股東要求而已經採取或將要採取的行動。紐約證券交易所監管機構的工作人員將審查商業計劃。如果紐約證券交易所監管機構接受該計劃,公司將收到書面通知,並將接受定期審查,包括季度監督該計劃的遵守情況。如果紐約證券交易所監管機構不接受該計劃,則公司將接受退市程序。

The Company intends to submit a plan to regain compliance with the continued listing standards within the required timeframe. The Company expects that upon completion of an initial business combination it will have at least 300 public stockholders. The Notice has no immediate impact on the Company's Class A common stock, and provided NYSE Regulation approves the plan, the Company's Class A common stock is expected to continue to be listed and traded on the NYSE American LLC through September 30, 2024, subject to the Company's compliance with other NYSE listing standards and periodic review by NYSE Regulation of the Company's progress under the plan.

該公司打算在規定的時間範圍內提交一份計劃,以恢復對持續上市標準的遵守。該公司預計,在完成初始業務合併後,它將擁有至少300名公衆股東。該通知對公司的A類普通股沒有直接影響,只要紐約證券交易所監管機構批准該計劃,公司的A類普通股預計將在2024年9月30日之前繼續在紐約證券交易所美國有限責任公司上市和交易,前提是該公司遵守其他紐約證券交易所上市標準,以及紐約證券交易所監管機構對該計劃進展情況的定期審查。

About Berenson Acquisition Corp. I

關於貝倫森收購公司 I

The Company is a special purpose acquisition corporation focused on identifying a leading technology-enabled services or software company led by a passionate management team of subject matter experts.

該公司是一家特殊目的收購公司,專注於尋找由充滿激情的主題專家管理團隊領導的領先技術支持服務或軟件公司。

The Company is affiliated with Berenson Holdings LLC ("Berenson"), a merchant bank founded in 1990 with two principal lines of business: investment banking and private equity investing. Berenson was co-founded by Jeffrey Berenson, the former head of M&A and founder and co-head of merchant banking at Merrill Lynch, and is a trusted financial advisor to executives, founders, boards, family offices, financial sponsors, pension funds and government-related entities seeking to drive transformational growth as well as other value creation and preservation initiatives. On December 22, 2023, the Company entered into a definitive business combination agreement with Custom Health Inc., a Delaware corporation, and Continental Merger Sub Inc., a Delaware corporation and wholly-owned direct subsidiary of the Company.

該公司隸屬於貝倫森控股有限責任公司(“貝倫森”),這是一家成立於1990年的商業銀行,擁有兩條主要業務領域:投資銀行和私募股權投資。貝倫森由美林證券前併購主管、創始人兼商業銀行業務聯席主管傑弗裏·貝倫森共同創立,是尋求推動轉型增長以及其他價值創造和保護計劃的高管、創始人、董事會、家族辦公室、金融贊助商、養老基金和政府相關實體值得信賴的財務顧問。2023年12月22日,公司與特拉華州的一家公司Custom Health Inc. 和特拉華州的一家公司、公司的全資直接子公司Continental Merger Sub Inc. 簽訂了最終的業務合併協議。

Forward-Looking Statements

前瞻性陳述

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's plan to submit a business plan advising of actions it has taken or will take to regain compliance with the minimum public shareholders requirement by September 30, 2024. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Factors that may cause such differences include, without limitation, the Company's ability to timely prepare a business plan advising of actions it has taken or will take to regain compliance with the minimum public shareholders requirement by September 30, 2024, and other risks and uncertainties indicated from time to time in filings with the SEC, including the definitive proxy statement and the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, in each case under the heading "Risk Factors," and other documents the Company has filed, or will file, with the SEC. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

本新聞稿包括經修訂的1995年《私人證券訴訟改革法》所指的前瞻性陳述。其中某些前瞻性陳述可以通過使用 “相信”、“期望”、“打算”、“計劃”、“估計”、“假設”、“可能”、“應該”、“將”、“尋求” 等詞語來識別。此類聲明可能包括但不限於有關公司計劃在2024年9月30日之前提交商業計劃的聲明,說明其已採取或將要採取的行動,以恢復對最低公衆股東要求的遵守。前瞻性陳述是不是歷史事實的陳述。此類前瞻性陳述受風險和不確定性的影響,這可能導致實際結果與前瞻性陳述有所不同。可能導致此類差異的因素包括但不限於公司及時制定商業計劃的能力,就其爲在2024年9月30日之前恢復遵守最低公衆股東要求而已經採取或將要採取的行動提供建議,以及向美國證券交易委員會提交的文件中不時指出的其他風險和不確定性,包括最終委託書和公司截至2022年12月31日財年的10-K表年度報告,標題爲 “風險” 因素” 以及公司提交的其他文件,或將向美國證券交易委員會提起訴訟。提醒讀者不要過分依賴任何前瞻性陳述,這些陳述僅代表截至發佈之日。公司明確表示不承擔任何義務或承諾公開發布此處包含的任何前瞻性陳述的任何更新或修訂,以反映公司對該陳述的預期的任何變化或任何陳述所依據的事件、條件或情況的任何變化。

Contact:
Berenson Acquisition Corp. I
Josh Woodbridge
ir@berensonacquisitioncorp.com

聯繫人:
貝倫森收購公司 I
喬什·伍德布里奇
ir@berensonacquisitioncorp.com

Media Contact:
Prosek Partners
Forrest Gitlin
FGitlin@prosek.com

媒體聯繫人:
Prosek 合作伙伴
福雷斯特·吉特林
FGitlin@prosek.com

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論